FIELD: medicine; pharmaceuticals.
SUBSTANCE: pharmaceutical composition comprises an 11-deoxy-prostaglandin compound and a fatty acid ester derived from a fatty acid, having C6-C24 carbon atoms and glycerol. 11-deoxy-prostaglandin compound is preferably 11-deoxy-13,14-dihydro-15-keto-16,16-difluoro-prostaglandin compound of E1 type. 11-deoxy-prostaglandin compound can be stabilized by mixing said compound with said fatty acid ester. Composition is in the form of a capsule suitable for oral administration.
EFFECT: invention provides stabilization of the 11-deoxy-prostaglandin compound.
14 cl, 4 tbl, 2 ex
Authors
Dates
2018-04-19—Published
2013-07-26—Filed